RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 133 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,000 | -33.3% | 865 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $3,000 | +50.0% | 865 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $2,000 | -33.3% | 865 | +6.8% | 0.00% | -50.0% |
| Q1 2018 | $3,000 | -40.0% | 810 | -33.1% | 0.00% | 0.0% |
| Q4 2017 | $5,000 | -16.7% | 1,210 | -45.2% | 0.00% | -33.3% |
| Q3 2017 | $6,000 | 0.0% | 2,210 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $6,000 | -14.3% | 2,210 | +10.0% | 0.00% | -25.0% |
| Q1 2017 | $7,000 | – | 2,010 | +20000.0% | 0.00% | – |
| Q4 2016 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 10 | -99.3% | 0.00% | -100.0% |
| Q2 2016 | $3,000 | 0.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,000 | 0.0% | 1,500 | +36.4% | 0.00% | 0.0% |
| Q4 2015 | $3,000 | 0.0% | 1,100 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $3,000 | -25.0% | 1,100 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $4,000 | – | 1,100 | +1000.0% | 0.00% | – |
| Q1 2015 | $0 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |